BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 327981)

  • 21. Thiazolidin-2-cyanamides derivatives as novel potent
    Zhou TS; Wei B; He M; Li YS; Wang YK; Wang SJ; Chen JW; Zhang HW; Cui ZN; Wang H
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1736-1742. PubMed ID: 32928007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kinetics of hydrolysis of synthetic glucuronic esters and glucuronic ethers by bovine liver and Escherichia coli beta-glucuronidase.
    Tomasić J; Keglević D
    Biochem J; 1973 Aug; 133(4):789-95. PubMed ID: 4584027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjugation-deconjugation cycling of diflunisal via beta-glucuronidase catalyzed hydrolysis of its acyl glucuronide in the rat.
    Brunelle FM; Verbeeck RK
    Life Sci; 1997; 60(22):2013-21. PubMed ID: 9180355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation.
    Greim H; Bonse G; Radwan Z; Reichert D; Henschler D
    Biochem Pharmacol; 1975 Nov; 24(21):2013-7. PubMed ID: 1108881
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of microsomal glutathione transferase activity by reactive intermediates formed during the metabolism of phenol.
    Wallin H; Morgenstern R
    Chem Biol Interact; 1990; 75(2):185-99. PubMed ID: 2369785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of in vitro bioactivation of hydroquinone by phenol in bone marrow cells.
    Subrahmanyam V; Sadler A; Suba E; Ross D
    Drug Metab Dispos; 1989; 17(3):348-50. PubMed ID: 2568920
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro inhibition of DNA adduct formation by hindered hydroquinols and quinones.
    Colovai AI; Herdan J; Popovici C; Mihai C; Grigoras C; Voiculetz N; Nicolescu-Duvaz I
    Carcinogenesis; 1993 Jun; 14(6):1137-41. PubMed ID: 8508499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of RNA synthesis and interleukin-2 production in lymphocytes in vitro by benzene and its metabolites, hydroquinone and p-benzoquinone.
    Post GB; Snyder R; Kalf GF
    Toxicol Lett; 1985 Dec; 29(2-3):161-7. PubMed ID: 2418539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of hydroquinone and of benzoquinone on the ciliary activity of the tracheal mucosa of the rat in vitro].
    Guillerm R; Badré R; Hée J
    C R Acad Hebd Seances Acad Sci D; 1968 Jan; 266(5):528-30. PubMed ID: 4969237
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase.
    Peduto A; Scuotto M; Krauth V; Roviezzo F; Rossi A; Temml V; Esposito V; Stuppner H; Schuster D; D'Agostino B; Schiraldi C; de Rosa M; Werz O; Filosa R
    Eur J Med Chem; 2017 Feb; 127():715-726. PubMed ID: 27836196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines.
    Benites J; Valderrama JA; Rivera F; Rojo L; Campos N; Pedro M; José Nascimento MS
    Bioorg Med Chem; 2008 Jan; 16(2):862-8. PubMed ID: 17964791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibition of microsomal oxidation by o-benzoquinone derivatives].
    Kostiuk VA
    Biokhimiia; 1987 Mar; 52(3):355-8. PubMed ID: 3580408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relation between the oxidative biotransformation of hexachlorobenzene and its porphyrinogenic activity.
    van Ommen B; Hendriks W; Bessems JG; Geesink G; Müller F; van Bladeren PJ
    Toxicol Appl Pharmacol; 1989 Sep; 100(3):517-28. PubMed ID: 2789443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-glucaro-1,4-lactone: its excretion in the bile and urine and effect on the biliary secretion of beta-glucuronidase after oral administration in rats.
    Macfadyen A; Ho KJ
    Hepatology; 1989 Apr; 9(4):552-6. PubMed ID: 2925160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Net glucuronidation in different rat strains: importance of microsomal beta-glucuronidase.
    Dwivedi C; Downie AA; Webb TE
    FASEB J; 1987 Oct; 1(4):303-7. PubMed ID: 3115856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thiadiazole derivatives as New Class of β-glucuronidase inhibitors.
    Salar U; Taha M; Ismail NH; Khan KM; Imran S; Perveen S; Wadood A; Riaz M
    Bioorg Med Chem; 2016 Apr; 24(8):1909-18. PubMed ID: 26994638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, in vitro β-glucuronidase inhibitory potential and molecular docking studies of quinolines.
    Bano B; Arshia ; Khan KM; Kanwal ; Fatima B; Taha M; Ismail NH; Wadood A; Ghufran M; Perveen S
    Eur J Med Chem; 2017 Oct; 139():849-864. PubMed ID: 28865280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteroides J-37, a human intestinal bacterium, produces alpha-glucuronidase.
    Kim DH; Jang IS; Lee SW
    Biol Pharm Bull; 1997 Aug; 20(8):834-7. PubMed ID: 9300126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of D-glucaric acid in mammals: a free-radical mechanism?
    Marsh CA
    Carbohydr Res; 1986 Sep; 153(1):119-31. PubMed ID: 3779687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of human beta-D-glucuronidase and alpha-L-iduronidase by a trihydroxy pipecolic acid of plant origin.
    Cenci di Bello I; Dorling P; Fellows L; Winchester B
    FEBS Lett; 1984 Oct; 176(1):61-4. PubMed ID: 6489520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.